SCHEMBL4968815

SCHEMBL4968815

CN[C@H](C(=O)NC(c1ccc(F)cc1)[C@H](c1ccccc1)c1cc(F)cc(C(F)(F)F)c1)C(O)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 5/20 0.55
KCNH2 Q12809 3/20 0.55
TACR1 P25103 6/20 0.37
TACR3 P29371 2/20 0.37
SLC6A9 P48067 1/20 0.36
ULK1 O75385 1/20 0.35
CCR2 P41597 3/20 0.34
AKT1 P31749 1/20 0.34
SCN9A Q15858 1/20 0.33
ACP1 P24666 1/20 0.33
PTPN7 P35236 1/20 0.33
PTPN12 Q05209 1/20 0.33
PTPN13 Q12923 1/20 0.33
SSU72 Q9NP77 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGB1 P05556 1/20 0.33
ITGAV P06756 1/20 0.33
ITGA5 P08648 1/20 0.33
ITGB5 P18084 1/20 0.33
ITGB6 P18564 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971705 0.79 SLC6A9 (0.40) CETPKCNH2TACR1SLC6A9ULK1
SCHEMBL4968561 0.76 SLC6A9 (0.40) CETPKCNH2TACR1TACR3SLC6A9
SCHEMBL4971054 0.73 SLC6A9 (0.36) CETPKCNH2TACR1SLC6A9ULK1
SCHEMBL4971187 0.73 CETP (0.65) CETPKCNH2TACR1TACR3SLC6A9
SCHEMBL758782 0.71 CETP (1.00) CETPKCNH2
SCHEMBL759370 0.71 CETP (1.00) CETPKCNH2
SCHEMBL14244186 0.71 CETP (0.61) CETPKCNH2TACR1CCR2SCN9A
SCHEMBL14244185 0.71 CETP (0.61) CETPKCNH2TACR1CCR2SCN9A
SCHEMBL14244157 0.71 CETP (0.47) CETP
SCHEMBL760356 0.67 CETP (0.41) CETPTACR1SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed